The Rebound with Alexandra Boussommier (ImVitro)
What Startup Failure Teaches Founders About Resilience and Execution
Startup failure teaches founders resilience by reframing endings as learning, and execution discipline by highlighting the need for problem validation, market focus, adaptability, and courage to pivot or start again.
Failure as a Core Part of Entrepreneurship
Entrepreneurship is often portrayed as a success story, but initiatives like Les Assises du Rebond remind us that it is also a story of resilience, learning, and courage.
This episode features Alexandra Boussommier, founder of ImVitro, who openly shares lessons from shutting down a deeptech startup.
Building at the Intersection of Science and Health
Trained at Cambridge, MIT, and Imperial College, Alexandra spent six years building a company at the crossroads of science, healthcare, and technology.
ImVitro aimed to revolutionize in vitro fertilization using artificial intelligence, an ambitious vision in a highly regulated and complex sector.
Validating the Problem Before the Solution
One of Alexandra’s key lessons is the importance of validating the problem before building advanced technology.
Strong science and technical innovation are not enough. Without clear evidence of unmet needs and adoption pathways, execution risks outweigh vision.
Execution Matters as Much as Vision in Healthcare
In healthcare and deeptech, execution discipline is critical.
Alexandra emphasizes that:
- Regulatory constraints shape timelines
- Market access requires patience and focus
- Vision must be matched with operational rigor
Failure often exposes gaps not in ambition, but in execution.
Taking Risks and Reading Weak Signals
Entrepreneurship requires bold decisions, sometimes summarized as “go big or go home.”
Alexandra also highlights the importance of returning to the field, observing weak signals, and adjusting direction before challenges become irreversible.





